ELAB vs MRVL · rev $2.0M vs P/E 100, rev $5.16B
Elevai Labs, Inc. Common Stock (ELAB) versus Marvell Technology Group Ltd (MRVL) — a side-by-side from cached financials, not a winner call.
Elevai Labs, Inc. Common Stock (ELAB) is a biotechnology company listed on NASDAQ.
Marvell Technology Group Ltd (MRVL) is a semiconductors company listed on NASDAQ. It is led by Matthew J. Murphy.
Latest reported ELAB revenue for 2026-06-30 was $2.0M. Net income was -$7.9M. ELAB currently screens at market cap $6.5M.
Latest reported MRVL revenue for 2026-08-01 was $5.16B. Net income was $342.5M. MRVL currently screens at market cap $253.51B and trailing P/E 99.8.
ELAB currently screens at market cap $6.5M. MRVL currently screens at market cap $253.51B and trailing P/E 99.8.
Not investment advice. Open the ELAB and MRVL stock pages for the full models.
Not investment advice.